Search Login Register

T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) Summary

Description: A lymphoid leukemia characterized by a profound LYMPHOCYTOSIS with or without LYMPHADENOPATHY, hepatosplenomegaly, frequently rapid progression, and short survival. It was formerly called T-cell chronic lymphocytic leukemia.

Also Known As: Leukemia, T Cell, Chronic; Leukemia, Prolymphocytic, T-Cell; Leukemia, Lymphocytic, Chronic, T Cell; Leukemia, Lymphocytic, Chronic, T-Cell; Lymphocytic Leukemia, T Cell, Chronic Show All >>

Networked: 65 relevant articles (8 outcomes, 5 trials/studies) for this Disease

Key Drugs and Agents for T-Cell Prolymphocytic Leukemia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. alemtuzumab (Campath) : 6 outcomes 4 studies in 23 results : FDA 2
  2. fludarabine : 1 outcome in 2 results : IBA
  3. Cladribine : 1 outcome in 1 result : FDA 3 Generic
  4. Mitoxantrone (Novantrone) : 1 outcome in 1 result : FDA 8 Generic
  5. Cyclophosphamide (Cytoxan) : 1 outcome in 1 result : FDA 10 Generic
  6. Phosphotransferases (Kinase) : 4 results : IBA
  7. T-Cell Antigen Receptors (T-Cell Receptor) : 3 results : IBA
  8. Carbon Monoxide : 3 results : IBA
  9. Perforin : 2 results : IBA
  10. Oncogene Proteins (Oncogene Protein) : 2 results : IBA
Show All >>

Diseases Related to T-Cell Prolymphocytic Leukemia

  1. Neoplasms (Cancer)
  2. Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
  3. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
  4. Hematologic Neoplasms (Hematological Malignancy)
  5. Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
Show All >>

Key Therapies for T-Cell Prolymphocytic Leukemia

Efficacy Chart >>
  1. Stem Cell Transplantation : 1 outcome in 4 results
  2. Transplants (Transplant) : 1 outcome in 1 result
  3. Drug Therapy (Chemotherapy) : 1 study in 6 results
  4. Intravenous Infusions : 1 study in 1 result
  5. Splenectomy : 2 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.